fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Neuroprosthesis’ restores words to man with paralysis

Written by | 31 Aug 2021

University of California San Francisco Technology could lead to more natural communication for people who have suffered speech loss Researchers at UC San Francisco have successfully developed a… read more.

Rydapt receives NICE recomendation to treat agressive systemic mastocytosis – Novartis

Written by | 30 Aug 2021

Novartis welcomed the news that the National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination recommending Rydapt (midostaurin) for the treatment of aggressive… read more.

Gut bacteria and flavonoid-rich foods are linked and improve blood pressure levels

Written by | 30 Aug 2021

Hypertension Journal Report AMERICAN HEART ASSOCIATION Flavonoid-rich foods, including berries, apples, pears and wine, appear to have a positive effect on blood pressure levels, an association that is… read more.

FDA updates emergency use authorisation for mRNA 1273 in COVID-19 – Moderna

Written by | 29 Aug 2021

Moderna announced that the FDA has approved an update to the emergency use authorization for the Moderna mRNA 1273 COVID-19 vaccine to include a third dose for immunocompromised… read more.

Researchers develop novel strategy for tuberculosis vaccine

Written by | 29 Aug 2021

Innovators at Purdue University and Houston Methodist Research Institute have created a novel strategy for developing an effective vaccine for a widespread form of tuberculosis. Mycobacterium tuberculosis (Mtb)… read more.

Shorter course of antibiotics is effective for men with urinary tract infection

Written by | 28 Aug 2021

Researchers report that, for treatment of afebrile (non-feverish) men with a urinary tract infection (UTI), a 7-day course of ciprofloxacin or trimethoprim/sulfamethoxazole is a non-inferior alternative to a… read more.

Inflatable robotic hand gives amputees real-time tactile control

Written by | 28 Aug 2021

Prosthetic enables a wide range of daily activities, such as zipping a suitcase, shaking hands, and petting a cat. Massachusetts Institute of Technology An MIT-developed inflatable robotic hand… read more.

FDA approves Jardiance to treat adults living with heart failure with reduced ejection fraction – Boehringer Ingelheim + Eli Lilly

Written by | 27 Aug 2021

Jardiance (empagliflozin) 10 mg has been approved by the FDA to reduce the risk of cardiovascular death plus hospitalization for heart failure in adults with heart failure with… read more.

Study shows dramatic long-term complications in youth-onset type 2 diabetes

Written by | 27 Aug 2021

Researchers report that patients diagnosed with type 2 diabetes in their youth are, by young adulthood, at risk of serious complications. The findings from the TODAY2 study (Treatment… read more.

Ronapreve, the first monoclonal antibody treatment for COVID-19 approved for use in the UK – Regeneron + Roche

Written by | 26 Aug 2021

Following on from a thorough review of the evidence carried out by the MHRA, and recommendation by the Commission on Human Medicines (CHM), the government’s independent expert scientific… read more.

Ultra-processed food intake linked to inflammatory bowel disease

Written by | 26 Aug 2021

Consumption of ultra-processed foods appears to be linked to an increased risk of inflammatory bowel disease (IBD), researchers reported on July 15, 2021 in the BMJ/British Medical Journal…. read more.

Investigative immunotherapy for multiple myeloma produces deep and durable response

Written by | 25 Aug 2021

One infusion of an investigative chimeric antigen receptor-T cell therapy (CAR-T cell therapy) for multiple myeloma has produced early and durable responses in heavily pretreated patients, researchers reported… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.